Kura Oncology’s Ziftomenib Achieves Phase 2 Success in AML, Paving Way for Dual-Track Phase 3 Program

Ziftomenib, Acute Myeloid Leukemia (AML), NPM1 mutation, KMT2A rearrangement, Phase 3 trials, KOMET-001, KOMET-017, Menin inhibitor, Breakthrough Therapy Designation

Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination

Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration

CDC Orders Retraction of Research Papers and Removes Website Content Amid New Language Restrictions

CDC, research retraction, website content removal, language restrictions, LGBTQ, gender identity, scientific publications

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings

Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration